Bacterial production of recombinant contraceptive vaccine antigen from CatSper displayed on a human papilloma virus-like particle

被引:0
|
作者
Nand, K. N. [1 ]
Jordan, T. B. [1 ]
Yuan, X. [1 ]
Basore, D. A. [1 ,3 ]
Zagorevski, D. [1 ]
Clarke, C. [1 ]
Werner, G. [1 ]
Hwang, J. Y. [2 ]
Wang, H. [2 ]
Chung, J-j. [2 ,5 ]
McKenna, A. [4 ]
Jarvis, M. D. [4 ]
Singh, G. [4 ]
Bystroff, C. [1 ]
机构
[1] Rensselaer Polytech Inst, Dept Biol Sci, Troy, NY 12180 USA
[2] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT USA
[3] Mercy Univ, Dept Hlth & Nat Sci, Dobbs Ferry, NY USA
[4] Rensselaer Polytech Inst, Biores Core, Troy, NY USA
[5] Yale Univ, Sch Med, Dept Gynecol & Obstet, New Haven, CT USA
关键词
Contraceptive vaccine; CatSper; Ca2+ion channel; ESCHERICHIA-COLI; CAPSID PROTEIN; HPV VACCINATION; EXPRESSION; SEQUENCE; IMMUNOGENICITY; DOMAINS; BINDING; NONUSE; WOMEN;
D O I
10.1016/j.vaccine.2023.09.044
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CatSper is a voltage dependent calcium ion channel present in the principal piece of sperm tail. It plays a crucial role in sperm hyperactivated motility and so in fertilization. Extracellular loops of mouse sperm CatSper were used to develop a vaccine to achieve protection from pregnancy. These loops were inserted at one of the three hypervariable regions of Human Papilloma Virus (HPV) capsid protein (L1). Recombinant vaccines were expressed in E.coli as inclusion body (IB), purified, refolded and assembled into virus-like particles (VLP) in vitro, and adsorbed on alum. Four vaccine candidates were tested in Balb/C mice. All the constructs proved immunogenic, one showed contraceptive efficacy. This recombinant contraceptive vaccine is a non-hormonal intervention and is expected to give long-acting protection from undesired pregnancies.
引用
收藏
页码:6791 / 6801
页数:11
相关论文
共 50 条
  • [1] Bacterial production of recombinant contraceptive vaccine antigen from CatSper displayed on a human papilloma virus-like particle
    Nand, Kripa
    Jordan, Thomas B.
    Yuan, Xinmeng
    Basore, Danielle A.
    Clarke, Charlie
    Hwang, Jae Yeon
    Wang, Huafeng
    Chung, Jean-Ju
    Singh, Gurmej
    Jarvis, Michael D.
    Mckenna, Antigone M.
    Bystroff, Chris
    PROTEIN SCIENCE, 2023, 32 (12)
  • [2] Process intensification for the production of yellow fever virus-like particles as potential recombinant vaccine antigen
    Alvim, Renata G. F.
    Lima, Tulio M.
    Silva, Jerson L.
    de Oliveira, Guilherme A. P.
    Castilho, Leda R.
    BIOTECHNOLOGY AND BIOENGINEERING, 2021, 118 (09) : 3581 - 3592
  • [3] Development of recombinant baculovirus for high yield production of enterovirus 71 virus-like particle vaccine
    Hu, Yu-Chen
    Lin, Shi-Yeh
    NEW BIOTECHNOLOGY, 2014, 31 : S179 - S179
  • [4] Development of Recombinant Baculovirus for High Yield Production of Enterovirus 71 Virus-like Particle Vaccine
    Lin, Shih-Yeh
    Chung, Yao-Chi
    Hu, Yu-Chen
    MOLECULAR THERAPY, 2014, 22 : S123 - S123
  • [5] A recombinant HIV-1 virus-like particle vaccine: From concepts to a field study
    Wagner, R
    Deml, L
    Teeuwsen, V
    Heeney, J
    Shao, YM
    Wolf, H
    DEVELOPMENT AND APPLICATIONS OF VACCINES AND GENE THERAPY IN AIDS, 1996, 48 : 68 - 83
  • [6] RECOMBINANT-EXPRESSED VIRUS-LIKE PARTICLE PSEUDOTYPES AS AN APPROACH TO VACCINE DEVELOPMENT
    MCGUIGAN, LC
    STALLARD, V
    ROOS, JM
    PAYNE, LG
    VACCINE, 1993, 11 (06) : 675 - 678
  • [7] A Preclinical Immunogenicity Study of the Recombinant Human Papillomavirus Nine-Valent Virus-like Particle Vaccine
    Xu, Dan
    Li, Jia-Dai
    An, Jiao
    Ma, Xin-Xing
    Wang, Xiao-Liang
    Zhou, Zheng
    Liu, Hai-Ping
    Diao, Mei-Jun
    Jiang, Yuan-Xiang
    Zhou, Ling-Yun
    Tong, Xin
    Zhou, Chen-Liang
    VACCINES, 2024, 12 (12)
  • [8] Protective Humoral Immune Response Induced by Recombinant Virus-like Particle Vaccine Expressing Leishmania donovani Surface Antigen
    Yoon, Keon-Woong
    Chu, Ki Back
    Eom, Gi-Deok
    Mao, Jie
    Kim, Min-Ju
    Lee, Hyeryon
    No, Joo Hwan
    Quan, Fu-Shi
    ACS INFECTIOUS DISEASES, 2023, 9 (12): : 2583 - 2592
  • [9] Virus-like particle vaccine for the prevention of infection with oncogenic human papillomaviruses
    Madkan, V
    Brantley, J
    Sra, K
    Tyring, S
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB154 - AB154
  • [10] Characterization of a DNA vaccine expressing a human immunodeficiency virus-like particle
    Young, KR
    Smith, JM
    Ross, TM
    VIROLOGY, 2004, 327 (02) : 262 - 272